158
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria

ORCID Icon, ORCID Icon, , ORCID Icon, , & show all
Pages 307-312 | Published online: 18 May 2021

References

  • Myers B, Pavord S. Heritable thrombophilias: implications for pregnancy and current evidence for treatment. Obstetr Gynaecol. 2011;13:225–230. doi:10.1576/toag.13.4.225.27687
  • Centers for Disease Control and Prevention. Pregnancy mortality surveillance system; 2016 Available from: http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html. Accessed February 2, 2019.
  • Say L, Chou D, Gemmill A. Global causes of maternal deaths: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e329–e338. doi:10.1016/S2214-109X(14)70227-X
  • Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol. 2003;1:111. doi:10.1186/1477-7827-1-111
  • Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Br J Haematol. 2006;132(2):171–196. doi:10.1111/j.1365-2141.2005.05847.x
  • African Population and Health Research Center. Maternal health in Nigeria: facts and figures fact sheet June 2017. Adapted from the report: maternal health in Nigeria: a situation update; 2016. Available from: www.aphrc.org/publications/maternal-health-nigeria-situation-update/. Accesed April 30, 2021.
  • Agan TU, Monjok E, Akpan UB, Omoronyia OE, Ekabua JE. Trend and causes of maternal mortality in a Nigerian Tertiary Hospital: a 5-year retrospective study (2010–2014) at the University of Calabar Teaching Hospital, Calabar, Nigeria. Open Access Maced J Med Sci. 2018;6(6):1153–1158. doi:10.3889/oamjms.2018.220
  • Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing Clinical Research: An Epidemiologic Approach. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:Appendix 6B; 75.
  • Nelen WLDM, Steegers EAP, Eskes TKAB, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet Res Lett. 1997;350(9081):861. doi:10.1016/S0140-6736(97)24038-9
  • QIAGEN. QIAsymphony SP protocol sheet: DNA_Buffy_Coat_400_V6_DSP by Qiagen; 2019. Available from: www.qiagen.com. Accessed June 2, 2019.
  • Ghermann RB, Goodwin TM. Obstetric implications of activated protein C resistance and factor V Leiden mutation. Obstet Gynecol Surv. 2000;55(2):117–122. doi:10.1097/00006254-200002000-00026
  • Traven E, Ogrinc A, Kunej T. Initiative for standardization of reporting genetics of male infertility. Syst Biol Reprod Med. 2017;63:58–66. doi:10.1080/19396368.2016.1250181
  • Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901–908. doi:10.1016/S0140-6736(03)12771-7
  • Howley HE, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol. 2005;192:694–708. doi:10.1016/j.ajog.2004.09.011
  • Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Neonatal Med. 2002;12:267–273. doi:10.1080/jmf.12.4.267.273
  • Benedetto C, Marozio L, Salton L, Maulà V, Chieppa G, Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand. 2002;81:1095–1100. doi:10.1034/j.1600-0412.2002.811201.x
  • Muetze S, Leeners B, Ortlepp JR, et al. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand. 2008;87:635–642. doi:10.1080/00016340802112740
  • Nagy B, Tóth T, Rigó J, Karádi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet. 1998;53:478–481. doi:10.1111/j.1399-0004.1998.tb02599.x
  • Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertens 1979. 2005;46:1270–1274. doi:10.1161/01.HYP.0000188979.74172.4d.
  • Wang X, Bai T, Liu S, Pan H, Wang B. Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. PLoS One. 2014;9:e100789. doi:10.1371/journal.pone.0100789.
  • Dudding T, Heron J, Thakkinstian A, et al. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. J Thromb Haemost. 2008;6:1868–1875. doi:10.1111/j.1538-7836.2008.03134.x
  • Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol. 2005;105:182–192. doi:10.1097/01.AOG.0000146250.85561.e9
  • Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133–1134. doi:10.1016/S0140-6736(95)91803-5
  • Patel RK, Arya R. Venous thromboembolism: racial and ethnic influences. Therapy. 2008;5:169–175. doi:10.2217/14750708.5.2.169
  • Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis. 2010;29(4):489–496. doi:10.1007/s11239-009-0365-8
  • Hira B, Pegoraro RJ, Rom L, Moodley J. Absence of factor V Leiden, thrombomodulin and prothrombin gene variants in black south African women with pre-eclampsia and eclampsia. BJOG. 2003;110:327–328. doi:10.1046/j.1471-0528.2003.01090.x
  • National Centre for Biotechnology Information. 100 genome project; 2021. Available from: https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes. Accessed April 4, 2021.
  • Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010;115:5–13. doi:10.1097/AOG.0b013e3181c68907